Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

8.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.2K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

26
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
26
Group Design02:01

Group Design

9.8K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
9.8K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

19
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
19
Censoring Survival Data01:09

Censoring Survival Data

284
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
284
Crossover Experiments01:16

Crossover Experiments

4.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Flexible Seamless Phase 2/3 Design With Biomarker-Driven Subgroup Enrichment and Sample Size Re-Estimation.

Pharmaceutical statistics·2025
Same author

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials.

Statistics in medicine·2025
Same author

Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue Withdrawal.

The Journal of infectious diseases·2024
Same author

A generalized outcome-adaptive sequential multiple assignment randomized trial design.

Biometrics·2024
Same author

Flexible seamless 2-in-1 design with sample size adaptation.

Journal of biopharmaceutical statistics·2024
Same author

A plasma peptidomic signature reveals extracellular matrix remodeling and predicts prognosis in alcohol-related hepatitis.

medRxiv : the preprint server for health sciences·2024

Related Experiment Video

Updated: Oct 18, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.4K

Interim monitoring in sequential multiple assignment randomized trials.

Liwen Wu1, Junyao Wang1, Abdus S Wahed1

  • 1Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Biometrics
|September 27, 2021
PubMed
Summary
This summary is machine-generated.

Sequential multiple assignment randomized trials (SMARTs) can now incorporate interim analyses for early stopping. This new method (IM-SMART) maintains statistical integrity while potentially reducing sample size and trial duration.

Keywords:
adaptive treatment strategydynamic treatment regimegroup sequential analysisinterim monitoringsequential multiple assignment randomized trial

More Related Videos

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

14.5K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.1K

Related Experiment Videos

Last Updated: Oct 18, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.4K
Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

14.5K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.1K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Adaptive Trial Design

Background:

  • Sequential Multiple Assignment Randomized Trials (SMARTs) allow simultaneous comparison of multiple adaptive treatment strategies (ATSs).
  • SMARTs are typically longer than traditional trials, necessitating methods for efficient monitoring.
  • Existing frameworks for SMARTs lack provisions for interim analyses to enable early trial termination.

Purpose of the Study:

  • To introduce group sequential methods for interim monitoring in SMARTs (IM-SMART).
  • To enable early stopping of SMARTs for overwhelming efficacy.
  • To evaluate the performance of IM-SMART in terms of type I error, power, and sample size.

Main Methods:

  • Developed group sequential methods tailored for SMARTs, utilizing the multivariate chi-square distribution.
  • Proposed an interim monitoring in SMART (IM-SMART) framework.
  • Conducted simulation studies to assess the statistical properties of IM-SMART.

Main Results:

  • Simulation studies confirmed that IM-SMART effectively maintains the desired type I error rate and statistical power.
  • The proposed IM-SMART method demonstrated a reduced expected sample size compared to classical SMART designs.
  • The method was successfully illustrated by reanalyzing a real-world SMART concerning knee osteoarthritis treatments.

Conclusions:

  • IM-SMART provides a statistically sound approach for interim monitoring in SMARTs.
  • This method enhances the efficiency of SMARTs by allowing for early stopping and potentially reducing sample size.
  • IM-SMART is a valuable advancement for adaptive clinical trial designs, applicable to various therapeutic areas.